UBS analysts reiterated a Buy rating on Boston Scientific Corporation (NYSE:BSX) on February 05, 2026.
Boston Scientific Corporation operates in the Healthcare sector. The stock currently trades at $77.64 with a market capitalization of $136.0B.
reiterateNYSE:BSX
UBS Reiterates Buy Rating on Boston Scientific Corporation (BSX)
UBS analysts reiterated a Buy rating on Boston Scientific Corporation (NYSE:BSX) on February 05, 2026. Boston Scientific Corporation operates in the Healthcare sector. The stock…
